tiprankstipranks
Apyx Medical Corporation (APYX)
NASDAQ:APYX
US Market
APYX
Apyx Medical
RESEARCH TOOLSreports
Want to see APYX full AI Analyst Report?

Apyx Medical (APYX) Ratios

203 Followers

Apyx Medical Ratios

APYX's free cash flow for Q1 2026 was $0.63. For the 2026 fiscal year, APYX's free cash flow was decreased by $ and operating cash flow was $-0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.80 5.00 5.26 5.52 3.63
Quick Ratio
 4.79 4.26 4.56 4.74 2.63
Cash Ratio
 3.30 2.71 2.96 3.43 0.86
Solvency Ratio
 -0.17 -0.20 -0.45 -0.34 -1.59
Operating Cash Flow Ratio
 -0.83 -0.68 -1.68 -0.41 -1.71
Short-Term Operating Cash Flow Coverage
 -17.85 -18.69 0.00 0.00 0.00
Net Current Asset Value
$ 4.86M$ 6.46M$ 5.93M$ 18.04M$ 28.99M
Leverage Ratios
Debt-to-Assets Ratio
 0.07 0.59 0.60 0.49 0.02
Debt-to-Equity Ratio
 0.34 2.71 2.73 1.44 0.02
Debt-to-Capital Ratio
 0.25 0.73 0.73 0.59 0.02
Long-Term Debt-to-Capital Ratio
 0.23 0.71 0.70 0.55 0.00
Financial Leverage Ratio
 4.91 4.60 4.56 2.97 1.38
Debt Service Coverage Ratio
 -1.08 -1.01 -2.89 -6.33 -1.49K
Interest Coverage Ratio
 -1.51 -1.15 -3.19 -6.96 -1.57K
Debt to Market Cap
 0.03 0.24 0.60 0.37 0.00
Interest Debt Per Share
 0.18 1.07 1.26 1.18 0.02
Net Debt to EBITDA
 8.43 -1.31 -0.42 0.28 0.43
Profitability Margins
Gross Profit Margin
38.14%36.02%61.04%64.49%65.45%
EBIT Margin
-4.92%-12.20%-36.17%-35.92%-51.44%
EBITDA Margin
-5.69%-10.96%-34.93%-34.60%-49.44%
Operating Profit Margin
-7.71%-12.20%-39.18%-32.97%-52.94%
Pretax Profit Margin
-15.60%-20.50%-48.45%-40.65%-51.47%
Net Profit Margin
-16.42%-21.22%-48.78%-35.75%-52.09%
Continuous Operations Profit Margin
-16.19%-21.01%-48.98%-36.01%-52.30%
Net Income Per EBT
105.25%103.47%100.67%87.93%101.19%
EBT Per EBIT
202.32%168.09%123.68%123.31%97.24%
Return on Assets (ROA)
-14.55%-16.77%-36.18%-23.62%-44.78%
Return on Equity (ROE)
-90.62%-77.10%-165.12%-70.08%-61.69%
Return on Capital Employed (ROCE)
-8.04%-11.69%-34.82%-25.95%-59.02%
Return on Invested Capital (ROIC)
-7.97%-11.60%-34.59%-22.86%-58.64%
Return on Tangible Assets
-14.55%-16.77%-36.18%-23.62%-44.78%
Earnings Yield
-5.93%-7.60%-41.78%-20.63%-28.70%
Efficiency Ratios
Receivables Turnover
 4.38 3.15 3.11 3.73 2.44
Payables Turnover
 13.14 11.06 7.17 6.85 5.76
Inventory Turnover
 3.62 3.93 2.48 1.87 1.30
Fixed Asset Turnover
 8.79 7.99 7.14 7.33 5.87
Asset Turnover
 0.89 0.79 0.74 0.66 0.86
Working Capital Turnover Ratio
 1.21 1.14 0.93 1.18 1.13
Cash Conversion Cycle
 156.27 175.72 213.84 239.36 366.27
Days of Sales Outstanding
 83.28 115.87 117.46 97.77 149.62
Days of Inventory Outstanding
 100.77 92.86 147.31 194.83 279.99
Days of Payables Outstanding
 27.78 33.01 50.93 53.25 63.35
Operating Cycle
 184.05 208.74 264.77 292.60 429.61
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.19 -0.19 -0.51 -0.15 -0.59
Free Cash Flow Per Share
 -0.22 -0.22 -0.53 -0.17 -0.62
CapEx Per Share
 0.03 0.03 0.02 0.02 0.03
Free Cash Flow to Operating Cash Flow
 1.14 1.14 1.04 1.10 1.05
Dividend Paid and CapEx Coverage Ratio
 -7.03 -7.18 -25.00 -9.85 -20.08
Capital Expenditure Coverage Ratio
 -7.03 -7.18 -25.00 -9.85 -20.08
Operating Cash Flow Coverage Ratio
 -1.80 -0.20 -0.47 -0.14 -25.48
Operating Cash Flow to Sales Ratio
 -0.14 -0.15 -0.38 -0.10 -0.46
Free Cash Flow Yield
-5.85%-6.18%-33.42%-6.37%-26.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -16.49 -13.16 -2.39 -4.85 -3.48
Price-to-Sales (P/S) Ratio
 2.75 2.79 1.17 1.73 1.81
Price-to-Book (P/B) Ratio
 11.79 10.15 3.95 3.40 2.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -17.09 -16.19 -2.99 -15.69 -3.79
Price-to-Operating Cash Flow Ratio
 -19.21 -18.44 -3.11 -17.28 -3.98
Price-to-Earnings Growth (PEG) Ratio
 -0.14 0.22 -0.11 0.25 -0.07
Price-to-Fair Value
 11.79 10.15 3.95 3.40 2.15
Enterprise Value Multiple
 -39.97 -26.80 -3.76 -4.72 -3.24
Enterprise Value
 126.91M 155.17M 63.18M 85.56M 71.37M
EV to EBITDA
 -39.97 -26.80 -3.76 -4.72 -3.24
EV to Sales
 2.27 2.94 1.31 1.63 1.60
EV to Free Cash Flow
 -14.12 -17.02 -3.37 -14.80 -3.35
EV to Operating Cash Flow
 -16.12 -19.39 -3.50 -16.30 -3.52
Tangible Book Value Per Share
 0.32 0.35 0.40 0.78 1.09
Shareholders’ Equity Per Share
 0.31 0.34 0.40 0.77 1.09
Tax and Other Ratios
Effective Tax Rate
 -0.04 -0.02 -0.01 0.11 -0.02
Revenue Per Share
 1.35 1.25 1.35 1.51 1.29
Net Income Per Share
 -0.22 -0.27 -0.66 -0.54 -0.67
Tax Burden
 1.05 1.03 1.01 0.88 1.01
Interest Burden
 2.38 1.68 1.34 1.13 1.00
Research & Development to Revenue
 0.06 0.06 0.11 0.09 0.10
SG&A to Revenue
 0.57 0.68 0.90 0.93 1.08
Stock-Based Compensation to Revenue
 0.02 0.04 0.08 0.10 0.15
Income Quality
 0.87 0.72 0.77 0.28 0.87
Currency in USD